CRTX Share Price Performance
UK£0.10
0.01 (10.53%)
98.6% undervalued intrinsic discount
UK£7.26
Fair Value
Price UK£0.10
Somewhatcompetent UK£7.26
Fair ValueUK£7.26
Share Pricen/a
CRISM Therapeutics Corporation Stock Price
- 1 Narratives written by author
- 0 Comments on narratives written by author
- 1 Fair Values set on narratives written by author
CRTX Community Narratives
SO
Fair Value UK£7.26 98.6% undervalued intrinsic discount
Bright future for a healthy business - get in early!
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
Bright future for a healthy business - get in early!
Innovative niches in the market designed to tackle large problems. This company will be one to watch in the UK.Read more
5
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
SO
UK£7.26
98.6% undervalued intrinsic discount
Somewhatcompetent's Fair Value
Revenue
400% p.a.
Profit Margin
100%
Future PE
106x
Price in 2028
UK£10.14
Trending Discussion
Recently Updated Narratives
SO
Bright future for a healthy business - get in early!
Fair Value: UK£7.26 98.6% undervalued intrinsic discount
1 followerusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
CRISM Therapeutics Corporation Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
- -0.029
- 72.00%
- -5,952.00%
- 0%
About CRTX
- Founded
- 2016
- Employees
- n/a
- CEO
- WebsiteView website
CRISM Therapeutics Corporation develops a drug delivery technology for the clinical performance of cancer treatments for solid tumors through the local delivery of chemotherapy drugs. Its lead product is ChemoSeed, an implantable biodegradable drug delivery technology for the delivery of chemotherapy directly into cancer tissues. The company also offers formulation and consultancy services. The company was formerly known as Amur Minerals Corporation and changed its name to CRISM Therapeutics Corporation in May 2024. CRISM Therapeutics Corporation was founded in 2016 and is based in Road Town, the British Virgin Islands.
